Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pece

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
European Journal of Pharmacology|August 8, 1996
Hyporeactivity of mesenteric vascular bed in endotoxin-treated ratsD Mitolo-Chieppa, M Serio, M A Potenza, et al.
International Journal of Immunopathology and Pharmacology|January 9, 2008
Prognostic implications of NUMB immunoreactivity in salivary gland carcinomasE Maiorano, G Favia, S Pece, et al.
Oncogene|June 23, 2009
Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumorS Confalonieri, M Quarto, G Goisis, et al.
Microbios|January 1, 1994
Rochalimaea henselae organisms possess an elevated capacity of binding to peripheral blood lymphocytes from patients with cat scratch diseaseS Pece, A B Maffione, R Petruzzelli, et al.
Immunopharmacology and Immunotoxicology|May 1, 1996
In vitro effects of 3'-azido-3'-deoxythymidine (AZT) on normal human polymorphonuclear cell and monocyte-macrophage functional capacitiesC De Simone, A B Maffione, R Calvello, et al.
British Journal of Cancer|July 27, 2006
In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patientsV Mey, E Giovannetti, F De Braud, et al.
Immunopharmacology and Immunotoxicology|December 10, 1999
Helicobacter pylori infection and host cell responsesA Di Leo, C Messa, F Russo, et al.
Oncogene|October 26, 2010
Genomic characterization of asymptomatic CT-detected lung cancersE Belloni, G Veronesi, C Micucci, et al.
Oncogene|October 24, 2007
Breast cancer metastases are molecularly distinct from their primary tumorsM Vecchi, S Confalonieri, P Nuciforo, et al.
Nature Communications|December 3, 2024
Loss of NUMB drives aggressive bladder cancer via a RHOA/ROCK/YAP signaling axisF A Tucci, R Pennisi, D C Rigiracciolo, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
European Journal of Pharmacology|August 8, 1996
Hyporeactivity of mesenteric vascular bed in endotoxin-treated ratsD Mitolo-Chieppa, M Serio, M A Potenza, et al.
International Journal of Immunopathology and Pharmacology|January 9, 2008
Prognostic implications of NUMB immunoreactivity in salivary gland carcinomasE Maiorano, G Favia, S Pece, et al.
Oncogene|June 23, 2009
Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumorS Confalonieri, M Quarto, G Goisis, et al.
Microbios|January 1, 1994
Rochalimaea henselae organisms possess an elevated capacity of binding to peripheral blood lymphocytes from patients with cat scratch diseaseS Pece, A B Maffione, R Petruzzelli, et al.
Immunopharmacology and Immunotoxicology|May 1, 1996
In vitro effects of 3'-azido-3'-deoxythymidine (AZT) on normal human polymorphonuclear cell and monocyte-macrophage functional capacitiesC De Simone, A B Maffione, R Calvello, et al.
British Journal of Cancer|July 27, 2006
In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patientsV Mey, E Giovannetti, F De Braud, et al.
Immunopharmacology and Immunotoxicology|December 10, 1999
Helicobacter pylori infection and host cell responsesA Di Leo, C Messa, F Russo, et al.
Oncogene|October 26, 2010
Genomic characterization of asymptomatic CT-detected lung cancersE Belloni, G Veronesi, C Micucci, et al.
Oncogene|October 24, 2007
Breast cancer metastases are molecularly distinct from their primary tumorsM Vecchi, S Confalonieri, P Nuciforo, et al.
Nature Communications|December 3, 2024
Loss of NUMB drives aggressive bladder cancer via a RHOA/ROCK/YAP signaling axisF A Tucci, R Pennisi, D C Rigiracciolo, et al.
Pageof 4